CHANGED BY CANCER

What happens when an inherited piece of genetic code predicts the exact cancers that took your family members — not as an active diagnosis, but as a ticking probability map?

In this episode of Changed By Cancer, Dr. Randi Paynter sits down with author Tiffany Graham Charkosky (Living Proof: How Love Defied Genetic Legacy). Tiffany has never had cancer, but her life has been shaped by it. After losing her mother at age 30, her grandfather in his 50s, and her uncle at 41, an astute researcher helped her family uncover an inherited gene mutation: Lynch syndrome.

Tiffany shares the raw, rarely discussed reality of cancer previvorship: managing genetic guilt, facing prophylactic surgeries to remove her uterus and ovaries at age 30 and 40, closing the door on family-building, and mastering the annual colon prep ritual as a self-described "colonoscopy doula".

In our signature Epi Edit breaks, Dr. Paynter unpacks why historical guidelines like the Amsterdam criteria routinely miss modern small families, the deep psychosocial gaps in hereditary cancer care, and the revolutionary new frontier of cancer immunoprevention vaccines like the Nous-209 platform.

Resources & Links Mentioned:

• Tiffany Graham Charkosky’s Memoir: Living Proof: How Love Defied Genetic Legacy tiffanygrahamcharkosky.com
• Lynch Syndrome Overview & Genetic Guidelines (NCBI): https://www.ncbi.nlm.nih.gov/books/NBK1211/
• DNA Mismatch Repair Biology (Peltomäki et al., Gastroenterology): https://pubmed.ncbi.nlm.nih.gov/36706841/
• Full transcripts, citations, and show archives: https://changedbycancer.com/

Disclaimer: Dr. Randi Paynter is a cancer epidemiologist, not a clinician. The discussions on this show explore lived experiences and healthcare systems and do not constitute medical advice. Please consult your medical team for personal health decisions.

📋 Take the 60-Second Listener Survey Here:

https://forms.gle/2zdkpujDFca7YhjUA

A quick check-in and an exciting request for your input! After a stubborn back injury kept me away from the microphone last week, I am resting up off-camera and planning our next slate of standalone Epi Edit deep dives.

These standalone episodes are our space to pull back the curtain on the science, population data, and systemic healthcare policies that shape cancer care. But before hitting record on the next round, I want to know what you need and want to learn about most.

I've outlined six potential topics to explore:

1. Does Stress Really Play a Role in Cancer? Parsing biological data from "toxic positivity."
2. Clinical Trials as Treatment: Why trials exist, the history of research ethics in the U.S., and modern access barriers.
3. The Geography of Cancer Survival: How rural hospital closures, travel burdens, and provider deserts dictate outcomes.
4. Intergenerational Trauma & Epigenetics: Can the exposures and traumas of our ancestors leave molecular footprints in our DNA?
5. The Family Tree as an Epidemiologic Cohort: How historical vital records reveal multi-generational patterns standard clinic intake forms miss.
6. The Unspoken Epidemiology of Survivorship: Late-onset cardiac, metabolic, and physical realities long after "ringing the bell."

Have an idea that isn't on this list? The survey has an open space to submit your own burning questions directly!

Coming Soon on Changed By Cancer:

Stay tuned for upcoming guest episodes, including a conversation with a woman who discovered in her late 20s that a pattern of early family losses was driven by an inherited genetic mutation, alongside an interview with a clinical cancer genetic counselor.

• Website & Guest Pitching: https://ChangedByCancer.com
• Connect on Facebook: https://www.facebook.com/ChangedByCancerPod/
• Support the Show: Please subscribe, rate the show on Apple Podcasts or Spotify, and share this update with a friend or caregiver who values evidence-based cancer conversations!

When someone receives a cancer diagnosis, the impact is never confined to the individual patient. It sends an immediate shockwave through an entire family, transforming spouses, partners, parents, and children overnight into primary advocates, home clinicians, and logistical anchors.

In this episode of Changed By Cancer, host Dr. Randi Paynter sits down with Charlotte Bayala, host of The Cancer Caregiver and Caregiver Breathing Room. For nearly fourteen years, Charlotte has walked beside her husband through an aggressive, incurable variant of papillary thyroid cancer — navigating nine surgeries, major anatomical complications, and repeated relocations between academic cancer centers.

Charlotte pulls back the curtain on the invisible labor of informal caregiving, how our medical infrastructure takes family care for granted, and what it truly looks like to establish boundaries, protect your children, and reclaim your own identity and nervous system.

In This Episode:

• The Ecosystem of Cancer

• Diagnosis Day: Facing Tall Cell Variant Thyroid Cancer

• The Epi Edit: Aggressive Histologies & Radioactive Iodine Resistance

• 14 Years, 9 Surgeries & The Persistence of Patient Advocacy

• Creating Family Containers: Shielding Children & Gatekeeping

• The Epi Edit: Psychoneuroimmunology & The Physical Toll of Caregiving

• Founding The Cancer Caregiver & Moving Beyond Empty Catchphrases

• The Epi Edit: The $600 Billion Economic Reality of Unpaid Care

• Immediate Clinical Reforms: How Healthcare Can Support Caregivers

Connect with Charlotte Bayala:

• Website: https://www.charlottebayala.com/

• Listen to The Cancer Caregiver: https://www.cancercaregiverpodcast.com

• Listen to Caregiver Breathing Room: https://www.charlottebayala.com/caregiver-breathing-room

• Connect with Charlotte on Instagram: https://www.instagram.com/cancercaregiverpodcast/

• Connect with Charlotte on YouTube: https://www.youtube.com/@cancercaregiver

• Connect with Charlotte on LinkedIn: https://www.linkedin.com/in/charlottebayala/

Resources:

1. Caregiver Advocacy & Practical Support

• Family Caregiver Alliance (FCA) / National Center on Caregiving https://www.caregiver.org/

Offers state-by-state caregiver resource locators, practical skill sheets (e.g., wound care and managing medications at home), and webinars focused on family dynamics and boundary setting.

• Cancer Support Community (CSC) – Caregiver Helpline & Registry https://www.cancersupportcommunity.org/

Provides a dedicated, toll-free helpline (888-793-9355) staffed by oncology social workers, alongside free virtual support groups specifically for family caregivers.

• Triage Cancer – Caregiver Legal & Financial Toolkit https://triagecancer.org/

A national nonprofit offering practical guides on navigating employment rights (FMLA, ADA accommodations), disability insurance, medical leave, and healthcare appeals for caregivers.

2. Disease-Specific Clinical Resources (Thyroid Cancer)

• ThyCa: Thyroid Cancer Survivors’ Association https://thyca.org/

A global non-profit providing support groups, education, and specialist-reviewed materials specifically covering advanced, persistent, and radioactive iodine-refractory thyroid cancer variants.

• American Thyroid Association (ATA) – Clinical Management Guidelines https://www.thyroid.org/

Publicly accessible patient and family education brochures detailing the behavior, monitoring pathways, and targeted therapies for aggressive thyroid histologies.

3. Epidemiologic Research, Health Policy & Economics

• AARP Public Policy Institute – Valuing the Invaluable Report Series https://www.aarp.org/pri/departments/ppi/

The landmark economic analysis mapping the $600 billion national economic contribution and out-of-pocket costs borne by informal family caregivers.

• National Cancer Institute (NCI) – Informal Caregivers in Cancer Care (PDQ®) https://www.cancer.gov/about-cancer/coping/family-friends/family-caregivers-pdq

Comprehensive, evidence-based clinical summaries reviewing the psychoneuroimmunology, distress prevalence, and biological morbidity associated with oncology caregiving.

• Memorial Sloan Kettering (MSK) – Talking with Children About Cancer Program https://www.mskcc.org/experience/patient-support/counseling/talking-with-children

Clinical guidelines and parenting resources designed to help families navigate boundaries, communication, and age-appropriate support when a parent is living with cancer.

For More Information:

• Full clinical citations, research references, and transcripts: https://ChangedByCancer.com

• Watch full video episodes on YouTube: https://www.youtube.com/@ChangedByCancer

Disclaimer: Dr. Randi Paynter is a cancer epidemiologist, not a medical clinician. Conversations on this show explore personal experiences and systemic issues in healthcare; they are not intended as individual medical advice. Consult your personal care team for all health-related decisions.

"So to me, the chemo was a healing experience. I felt good from it." — Marissa

In Part One, Marissa described a decade-long path through progressive Multiple Sclerosis and an aggressive Stage III breast cancer diagnosis that arrived, paradoxically, as a second chance at life. In Part Two, host Dr. Randi Paynter continues the conversation as Marissa begins the chemotherapy regimen designed to treat her cancer — and instead finds that it starts undoing years of neurological damage.

Marissa opens by describing what it's actually like to navigate specialty medication costs and insurance approval, even with pharmacist training and a physician husband in her corner — a candid look at how little clinical fluency protects patients from a system built around cost containment.

As she moves through her ACT chemotherapy regimen, Marissa and Dr. Paynter trace an unexpected biological overlap: two of the chemo drugs prescribed for her cancer appear to have halted her multiple sclerosis in its tracks. This episode's Epi Edit breaks down the emerging science of Immune Reconstitution Therapy (IRT) — the paradigm reshaping how neurologists think about durable MS remission.

Marissa also walks through the surprisingly complex logistics of cold capping to preserve her hair during chemo, and reveals a hereditary ATM gene mutation that shaped both her diagnosis and her family's future cancer screening.

The episode traces her long, nonlinear recovery — from a single Taxotere dose that set her MS back overnight, to relearning to walk, to driving independently for the first time in years.

Correction & Clarification: At approximately 13 minutes into this conversation, Marissa references doxorubicin and cyclophosphamide as having been used clinically to treat aggressive multiple sclerosis. Cyclophosphamide does have documented clinical use in aggressive MS (see research below). Doxorubicin's disease-modifying effects on MS-like disease, however, have so far been demonstrated in animal models only — it is not an established clinical treatment for MS in humans. We're noting this correction for accuracy, and thank Marissa for catching and clarifying it after we spoke.

In this episode, we discuss:

• The Specialty Medication Trap: Why pharmacological training and even a physician spouse can't shield patients from insurance-driven drug pricing and access barriers.
• A Chemo-Induced MS Remission: How two of the chemotherapy drugs used to treat Marissa's breast cancer appear to have halted her multiple sclerosis — and the emerging science of Immune Reconstitution Therapy (IRT).
• Cold Capping, Demystified: The dry ice, timing, and cost logistics behind scalp cooling to prevent hair loss during chemo — and why access to it shouldn't be limited to those who can afford it.
• The ATM Gene: A hereditary risk factor beyond BRCA1/BRCA2, and what a moderate-penetrance mutation means for lifetime breast and pancreatic cancer risk.
• A Long, Nonlinear Recovery: Physical therapy, a serious MS flare triggered by a single chemo dose, and the slow return of mobility and independence — including driving again.
• Becoming Your Own Medical Archivist: What happens when your entire care team turns over, and why documenting your own history is essential.

Go to ChangedByCancer.com for show notes, research citations, and resource links.

Research articles & links referenced:

Immune Reconstitution Therapy Overview: Lünemann JD, Ruck T, Muraro PA, Bar-Or A, Wiendl H. Immune reconstitution therapies: concepts for durable remission in multiple sclerosis. Nat Rev Neurol. 2020 Jan;16(1):56-62. doi: 10.1038/s41582-019-0268-z. Epub 2019 Oct 24.

Scalp Cooling Therapy: Kaufman L, Valentic L, Malley L, Icksarus C, Rose L, Dulmage B. Scalp cooling therapy in chemotherapy-induced alopecia: addressing variability in cooling duration and efficacy. Support Care Cancer. 2025 Nov 1;33(11):1005. doi: 10.1007/s00520-025-10058-y. PMID: 41174233; PMCID: PMC12578718.

Cold Caps & Scalp Cooling — General Overview: Breastcancer.org, "Cold Caps and Scalp Cooling Systems." https://www.breastcancer.org/treatment-side-effects/hair-loss/cold-caps-scalp-cooling

The ATM Gene & Breast Cancer: Stucci LS, Internò V, Tucci M, Perrone M, Mannavola F, Palmirotta R, Porta C. The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice. Genes (Basel). 2021 May 13;12(5):727. doi: 10.3390/genes12050727. PMID: 34068084; PMCID: PMC8152746.

Chemotherapy & MS — Clinical Case Series: Santos-García D, Prieto JM, Lema M. Clinical course of multiple sclerosis in patients treated with cytostatic drugs for cancer. Rev Neurol. 2009 Jan 16-31;48(2):71-4. Spanish. PMID: 19173204.

Chemotherapy & MS — Exacerbation Case Report: Rust H, Kuhle J, Kappos L, Derfuss T. Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy. Neurol Neuroimmunol Neuroinflamm. 2016 Mar 9;3(2):e215. doi: 10.1212/NXI.0000000000000215. PMID: 27027097; PMCID: PMC4794809.

MS Treatment Research: Shimizu K, Agata K, Takasugi S, Goto S, Narita Y, Asai T, Magata Y, Oku N. New strategy for MS treatment with autoantigen-modified liposomes and their therapeutic effect. J Control Release. 2021 Jul 10;335:389-397. doi: 10.1016/j.jconrel.2021.05.027. Epub 2021 May 24. PMID: 34033858.

Related listening: Rachel's episode ("The No-Bull Truth") for more on staying organized as your own medical advocate.

Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

"When I got diagnosed with breast cancer, all of a sudden I realized I could die. And then I felt terrible about how little I thought of my life and realized that I actually had a wonderful life... Being alive meant I could see my family, read a book, go outside. I could not believe how much I didn't see that I had all along." — Marissa

In 2012, Marissa was a 42-year-old mother living in South Florida when she experienced a severe, sudden, and inexplicable major depressive episode. It would take years — and a series of subtle physical disconnects — to learn that this psychological shift was actually the initial onset of progressive Multiple Sclerosis.

In Part 1 of this special two-part feature, host Dr. Randi Paynter sits down with Marissa to trace a decade-long journey through neuroinflammatory disease, progressive mobility shifts, systemic insurance step therapy, and the psychological weight of chronic isolation.

Note on Clinical Background: Marissa trained and previously worked as a licensed pharmacist. While she is not currently practicing, her educational background naturally informed how she understood her treatments and parsed complex drug interactions. We highlight this background not to set an expectation, but to emphasize the exact opposite: navigating complex diagnoses, insurance bureaucracy, and drug protocols is daunting for anyone, and patients without a medical or science background should never feel intimidated or place unreasonable expectations on themselves to master these systems alone.

When a routine mammogram revealed aggressive Stage 3 breast cancer, Marissa experienced a reaction her oncologist never expected: pure gratitude for a second chance to fight for her life.

We also feature another installment of The Epi Edit, where Dr. Paynter steps outside the interview to analyze the neuroepidemiology of the MS prodrome and the structural mechanisms behind insurance step therapy.

In this episode, we discuss:

• The MS Prodrome: Why severe psychiatric and cognitive shifts frequently precede motor impairment in neuroinflammatory conditions.
• Diagnostic Misdirection: Bouncing between specialists, joint hypermobility, and the fear of hereditary neurological conditions.
• The Emotional Toll of Mobility Devices: Navigating the psychological boundary from walking poles to full-time wheelchair reliance.
• The Insurance Step Therapy Trap: How cost-containment protocols force patients to "fail" older, less effective drugs before approving advanced therapies.
• The Power of Public Advocacy: How a single social media comment bypassed a months-long insurance wall to secure second-year chemotherapy coverage for MS.
• A Surreal Perspective Shift: Why hearing a Stage 3 breast cancer diagnosis felt like an immediate lifeline after years of progressive disability.

Go to ChangedByCancer.com for show notes, research citations, and resource links.

Research articles & links referenced:

• Understanding the MS Prodrome: Makhani N, Tremlett H. The multiple sclerosis prodrome. Nat Rev Neurol. 2021 Aug;17(8):515-521. doi: 10.1038/s41582-021-00519-3. Epub 2021 Jun 21. PMID: 34155379; PMCID: PMC8324569.
• More on the MS Prodrome: Chertcoff AS, Ruiz-Algueró M, Yusuf F, Zhao Y, Zhu F, Marrie RA, Tremlett H. Psychiatric morbidity during the multiple sclerosis prodrome is associated with future disability. Mult Scler. 2025 Dec;31(14):1619-1628. doi: 10.1177/13524585251382801. Epub 2025 Oct 26. PMID: 41139832; PMCID: PMC12644253.
• Insurance Step Therapy & Access: Mizell R. The Impact of Insurance Restrictions in Newly Diagnosed Individuals With Multiple Sclerosis. Int J MS Care. 2024 Jan-Feb;26(1):17-21. doi: 10.7224/1537-2073.2022-069. Epub 2024 Jan 5. PMID: 38213675; PMCID: PMC10779716.
• Breast Cancer Staging & Curative Intent: National Cancer Institute (NCI) Comprehensive Overview on Stage III Estrogen Receptor-Positive Breast Cancer. https://www.cancer.gov/types/breast/stages

Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

"Every day that I wake up and I don't have a new tumor, I'm adding to the survivorship data. So you have to live with a certain amount of uncertainty... I would like to curl up at night with a whole sheaf of data that doesn't exist yet, because I'm the one who's helping to create it." — Deborah

When we evaluate health metrics on a macro scale, we often treat long-term oncology survivorship as a finished equation — a simple box checked after a patient rings a bell. But the actual infrastructure of survival is far more complex, held together by human relationships, psychological boundaries, and systemic privileges.

In the conclusion of this special two-part feature, titled "The Elite Runner of Survivors," host Dr. Randi Paynter sits down with health sciences librarian Deborah to document the raw, unfiltered realities of long-term, advanced survivorship. After severe eye toxicities forced her to discontinue her dual combination targeted therapies (Tafinlar + Mekinist) in February 2020, Deborah walked off the edge of established clinical guidelines to navigate life as a true biological outlier.

In this episode, we move past the clinical trials to explore how families establish boundaries in a crisis, how we navigate profound grief and loss within a medical space, and how Deborah pivoted her entire career to train the next generation of healthcare providers.

We discuss:

• Parenting in a Crisis: The deliberate strategies Deborah used to protect her young sons from a climate of fear.
• The Epi Edit: The molecular science of V600 BRAF/MEK dual pathway inhibition and why combining toxic agents can paradoxically balance out specific side effects.
• The Phlebotomy Desk Bond: A tribute to Bakari, a nursing student from the Gambia whose tragic loss deeply impacted Deborah's care journey.
• The Career Transformation: How Deborah transitioned into academic health sciences librarianship, teaching medical and nursing students how to navigate evidence-based practice.
• Delivering Bad News: Reflecting on teaching medical students and the raw memory of finding out about her own diagnosis over the phone.
• The "Elite Runner" Deficit: What it actually feels like to cope with PTSD, survivor's guilt, and "scanxiety" when your clinic graduates you to annual MRIs.

-- Go to ChangedByCancer.com for show notes, resources, and links to Deborah's blog I'll Live

Resources mentioned:

• BRAF and MEK Pathway Inhibition: Subbiah V, Baik C, Kirkwood JM. Clinical Development of BRAF plus MEK Inhibitor Combinations. Trends Cancer. 2020 Sep;6(9):797-810. doi: 10.1016/j.trecan.2020.05.009. Epub 2020 Jun 13. PMID: 32540454. https://www.sciencedirect.com/science/article/pii/S2405803320301643
• The Breakthrough Documentary: https://www.uncommonproductions.com/breakthrough
• Deborah's Blog: I'll Live https://ill-live.com/

Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

In April of 2013, Deborah was a busy mother of two young boys living in Brooklyn when a spot on her back came back positive for malignant melanoma. A sentinel lymph node biopsy was clear, but the pathology noted "melanoma in transit" — malignant cells already on their way to other parts of her body.

By September of 2014, the "bad stuff" had landed in her lungs. Her oncologist recommended a clinical trial combining a short course of radiation with a novel immunotherapy drug named Ipilimumab (Yervoy). But after just two infusions, Deborah developed severe, life-threatening colitis, forcing her team to halt the therapy entirely.

Then came the spring of 2015. Within a day of being told her lungs showed No Evidence of Disease, Deborah woke up and realized she couldn't find the words to speak. An emergency MRI revealed nine active brain tumors.

In this first part of a special two-part feature, host Dr. Randi Paynter sits down with Deborah to trace a medical timeline that broke the speed limit of standard textbook guidelines. It is a story of rapid clinical pivots, genomic sequencing, and a quiet, non-invasive laser surgery where physicians played "Space Invaders" with her tumors while Deborah listened to Satie.

We also bring back The Epi Edit, a recurring segment where Dr. Paynter steps outside the conversation to analyze the epidemiology and science behind the lived experience. In this episode, we explore the biology of Immune-Related Adverse Events (irAEs) and why severe immunotherapy toxicities are historically correlated with exceptionally strong tumor response rates.

In this episode, we discuss:

• The "In-Transit" Alert: Why a skin lesion that refuses to heal is a critical warning sign.

• The Trial Experience: Why Deborah immediately agreed to be a clinical "guinea pig".

• The Epi Edit: The clinical paradox of high-grade immunotherapy toxicities and long-term survival.

• Gamma Knife Surgery: Demystifying non-invasive laser-guided brain surgery.

• Steroid Mania: Navigating the sleepless, hyper-chatty reality of high-dose dexamethasone.

• I'll Live: How Deborah used writing as a cognitive lifeline and connected with a patient in Northern Ireland.

-- Go to ChangedByCancer.com for show notes, blog links, and resources

Research articles & links referenced:

• Deborah's Blog: I'll Live https://ill-live.com/

• Gamma Knife Overview: A patient-friendly guide explaining how focused radiation beams treat specific brain areas without incisions. https://www.mayoclinic.org/tests-procedures/brain-stereotactic-radiosurgery/about/pac-20384679

• Understanding Immunotherapy: What Is Immunotherapy? — An accessible overview of how these treatments utilize the body's own immune system to recognize and fight cancer cells. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy.html

• Targeted Cancer Therapies: A clear explanation of how "precision medicine" drugs are engineered to block specific proteins that allow cancer cells to grow. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies

Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

When we are thrown into a health crisis, our brains desperately search for certainty through anchors, maps, timelines, and data. In the United States, the absolute gold standard for tracking population-level oncology data is a public health system called SEER (Surveillance, Epidemiology, and End Results) managed by the National Cancer Institute.

In this episode of The Epi Edit, cancer epidemiologist Dr. Randi Paynter pulls back the curtain on how SEER works under the hood, analyzing its 50-year history tracking cancer trends, its specific regional and metropolitan footprint, and what it intentionally includes and excludes — such as non-melanoma skin cancers and in situ cervical cancers.

Crucially, Dr. Paynter introduces a vital data-literacy framework designed to protect a patient's peace of mind: learning how to analyze the denominator. By contrasting the systemic, geographic, and socioeconomic realities of a rural patient in Montana with an urban patient in the Greater Bay Area of California, this episode demonstrates how broad percentages create mathematical fictions that flatten human experiences and hide critical health disparities. Learn how to ask the right questions in the doctor's office to move past flat averages and toward personalized health advocacy.

In this episode, we discuss:

• The psychological search for certainty and data anchors following a diagnosis.

• What SEER stands for, its funding structure, and its historical role since 1973.

• How representative sampling works across state and metropolitan registries.

• The definitions of Incidence vs. Mortality and Survival in public health data.

• The operational boundaries of data collections: Why minor skin cancers are excluded.

• The basic math of a statistic: Shifting focus from the numerator to the denominator.

• Contrasting human realities: The structural hurdles of rural Montana vs. urban California.

• How a flattened denominator masks disparities and advantages simultaneously.

• Slicing the denominator: Using specific variables to drive personalized medicine and self-advocacy.

-- Go to ChangedByCancer.com for show notes and episode links

Connect with the Community:

-- Free Patreon Community Space: https://patreon.com/ChangedByCancer?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

-- Facebook: https://www.facebook.com/ChangedByCancerPod/

-- Instagram: @changedbycancer

Data Systems & Historical Context:

-- National Cancer Institute SEER Program: seer.cancer.gov

-- National Center for Health Statistics: cdc.gov/nchs

Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

When we talk about cancer, we often talk about it in isolation — as a private medical crisis. But cancer doesn't happen in a vacuum. It happens to people who live in specific communities, navigate specific systems, and face distinct structural realities.

In this inaugural episode of The Epi Edit, host Dr. Randi Paynter steps behind the mic for a solo session to outline the mission of this new format and dismantle a deeply flawed framework that has dominated public health for decades: the patient-blame narrative.

Dr. Paynter shares her own educational journey and evaluates how traditional healthcare frameworks hyper-focus on individual "lifestyle choices" or "risky behaviors" while systematically ignoring structural limitations. From the reality of food deserts and SNAP constraints to geographical limitations, rural gym deserts, and involuntary environmental exposures, this episode shifts the focus away from personal failure and directly toward systemic bottlenecks.

Additionally, this episode introduces the four core pillars of the Changed By Cancer framework — Learning, Communicating, Empathy, and Policy — and details the launch of a free, independent community space designed to foster open discussion outside of social media algorithms.

In this episode, we discuss:

• The definition of epidemiology and how it differs from clinical oncology and pathology.

• The dual meaning behind the name "The Epi Edit".

• Dismantling the "individual blame" framework in traditional public health messaging.

• How food deserts, SNAP budgets, and neighborhood safety dictate choices.

• Involuntary environmental exposures vs. lifestyle preferences.

• The four core pillars driving the mission of Changed By Cancer.

• Our scope of focus on the traditional Western medical healthcare system.

• Why we are launching an independent, algorithm-free digital living room on Patreon.

-- Go to ChangedByCancer.com for show notes and episode links

Connect with the Community:

-- Free Patreon Community Space: https://patreon.com/ChangedByCancer?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

-- Facebook: https://www.facebook.com/ChangedByCancerPod/

-- Instagram: @changedbycancer

Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

Aiona came to California from Tonga when she was about a year old. She grew up in Sacramento, went on an LDS mission at twenty-one, came home, fell in love on what was essentially a second date, and eventually landed in Petaluma, CA — managing a Hampton Inn, raising two daughters, and working twelve-hour days until the day she noticed something had changed in her breast.

That was November 2025. The biopsy confirmed it: Stage III, hormone receptor-positive, HER2-negative breast cancer — eleven centimeters across three tumors, with lymph node involvement. Her oncology team moved fast. What followed was chemotherapy, a four-day hospital stay after she collapsed, a 25% reduction in her chemotherapy dose, and one more round of chemo to go.

But the thing Aiona came on this show to talk about wasn't the treatment. It was the silence.

Growing up in a Tongan community in California, Aiona had absorbed a belief she didn't have a name for: that when someone gets cancer, there's usually something they did to deserve it. She had believed this about other people. And when she got her own diagnosis, her first instinct was to hide it from nearly everyone, because she was afraid they would believe it about her. Her oncologist shut that framework down every time it came up: we cannot play that game.

This episode is also the debut of a new Changed By Cancer feature — The Epi Edit — where Dr. Paynter steps outside the conversation to put real epidemiological data behind what you just heard. In this episode, the numbers are striking. Native Hawaiians and Pacific Islanders represent about 0.4% of the U.S. population. For decades, their cancer data was buried inside the broader "Asian American" category, masking catastrophic disparities. A 2023 study in the Journal of the National Cancer Institute found that NHPI individuals between the ages of 20 and 49 have the highest cancer death rate of any racial or ethnic group in that age range in the country — higher than white, Black, Asian, Latino, or American Indian and Alaska Native populations of the same age. The gap is not biology. It is silence, and it is distance, and it is exactly the cultural stigma Aiona just spent this episode describing.

In this episode, Aiona and Dr. Randi Paynter discuss:

-- Stage III hormone receptor-positive, HER2-negative breast cancer: what it means when your team uses the words "locally advanced" and "goal is cure" in the same sentence

-- Illness attribution: the cross-cultural psychological instinct to find a moral cause for a random biological event — and why it's especially dangerous in communities where it operates quietly

-- The data masking problem: why Pacific Islander cancer disparities remained invisible for decades inside "Asian American" aggregate statistics, and what the 2023 JNCI study revealed when the data were finally disaggregated

-- Why Aiona kept her diagnosis secret from almost everyone at first — and the cousin whose own breast cancer story helped her change course

-- Neoadjuvant chemotherapy: why oncologists treat before they operate, explained the way it finally made sense to Aiona

-- What "the Red Devil" is, what it does to someone who loves to eat, and what a four-day hospital stay changed about her treatment plan

-- The meal train Aiona's LDS congregation has run twice a week since her diagnosis — and what the clinical research says about why consistent social support isn't just kindness; it's cancer care

-- Aiona's three things she wants her Tongan community to know: health is wealth, stop the blame game, and we don't have to reinvent the wheel on cancer education

-- And what a chance encounter at a sushi buffet taught her — without her knowing it — about how to respond the day someone complimented the wig she wasn't wearing yet

Aiona is a first-generation Tongan-American, a hotel manager, a wife, and a mother of two grown daughters living in Petaluma, California. She and Dr. Paynter were LDS missionary companions in Miami, Florida in 1991, and had not been in the same room together in thirty-four years when they sat down to record this episode.

-- Go to ChangedByCancer.com for show notes and episode links

Resources:

-- TOFA (To'utupu 'oe 'Otu Felenite Association) — Pacific Islander community organization serving the greater Sacramento area: tofainc.org

-- The No Bull**** Guide to Dealing with Cancer: https://www.nobullguidetodealingwithcancer.com/

Research articles referenced:

-- Haque AT, et al., JNCI: Journal of the National Cancer Institute, 2023. https://doi.org/10.1093/jnci/djad069

Find out more:

Social support networks and breast cancer

-- Kroenke CH, Kwan ML, Neugut AI, Ergas IJ, Wright JD, Caan BJ, Hershman D, Kushi LH. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun;139(2):515-27. doi: 10.1007/s10549-013-2477-2. Epub 2013 May 9. PMID: 23657404; PMCID: PMC3906043.

Just World Hypothesis

-- Lerner, M.J. (1980). The Belief in a Just World. In: The Belief in a Just World. Perspectives in Social Psychology. Springer, Boston, MA.

Illness attribution

-- Roesch SC, Weiner B. A meta-analytic review of coping with illness: do causal attributions matter? J Psychosom Res. 2001 Apr;50(4):205-19. doi: 10.1016/s0022-3999(01)00188-x. PMID: 11369026.

Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.